Dr. Alnahhas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Thomas Jefferson University. 909 Walnut St
2nd floor. COB building
Philadelphia, PA 19107Phone+1 800-533-3669
Summary
- I am a board-certified neurologist with subspecialty training in neuro-oncology.
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2018 - 2020
Virginia Commonwealth University Health SystemResidency, Neurology, 2015 - 2018
Damascus University Faculty of MedicineClass of 2012
Certifications & Licensure
DE State Medical License 2021 - 2025
NJ State Medical License 2020 - 2025
PA State Medical License Active through 2024
OH State Medical License 2018 - 2021
VA State Medical License 2014 - 2018- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 10 citationsScalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma.Ryan Miller, Andrew Song, Ayesha Ali, Muneeb Niazi, Voichita Bar-Ad
Frontiers in Oncology. 2022-01-01 - 32 citationsCharacterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis.Iyad Alnahhas, Mouaz Alsawas, Appaji Rayi, Joshua D Palmer, Raju Raval
Neuro-Oncology Advances. 2020-10-30 - 135 citationsTreatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A ReviewDenise Fabian, Maria del Pilar Guillermo Prieto Eibl, Iyad Alnahhas, Nikhil Sebastian, Pierre Giglio
Cancers. 2019-02-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
